Could these small-cap ‘special situations’ help you retire early?

Do these two small-caps have the potential to deliver stellar returns?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares of Molins (LSE: MLIN) jumped 28% last Thursday after it announced a conditional agreement to sell its Instrumentation & Tobacco Machinery division for £30m, with cash proceeds of £27.3m, net of taxes and fees. In the company’s last financial year, the division contributed £38.6m to group revenue, almost as much as its other division (Packaging Machinery), which contributed £41.5m. So, this is a significant disposal and will require shareholder approval.

Big discount?

The sale of the division will considerably strengthen Molins’ balance sheet and cash-positive position (net cash at the last year-end was £0.8m). It will also enable the company to accelerate investment in its Packaging Machinery division and acquire complementary businesses.

The company had net assets of £35.4m at the last year-end and says that the £27.3m from the sale of the Instrumentation & Tobacco Machinery division is similar to the book value of the division’s net assets. Even after the rise in the shares to 101.5p, Molins’ market cap is just £20.5m — a 42% discount to net assets. Put another way, if the shares traded in line with net asset value, the price would be 175p.

Meanwhile, the company says it’s “confident that the Continuing Group’s sales in 2017 are likely to be significantly ahead of last year” and has implicitly guided on £51m. If we apply the 0.78 times sales multiple at which the Instrumentation & Tobacco Machinery division is being sold to the remaining Packaging Machinery division, we get a share price of 197p.

There are execution risks with Molins’ strategy to acquire complementary businesses and the company also has a significant pension deficit. The current deficit recovery plan involves payments of £1.8m a year (increasing by 2.1% a year) through to 2029. Nevertheless, the size of the discount of the share price to my fair-value calculations of 175p-197p persuades me that there is potential for significant gains for buyers of the stock today.

Stamps licked?

Shares of Stanley Gibbons (LSE: SGI) shot up 18% to 13.13p on Friday after it announced an unsolicited approach from private equity group Disruptive Capital regarding a possible offer. However, the shares have retreated to 11p today after a further announcement from the stamps and coins company and an announcement from Disruptive Capital.

Stanley Gibbons had a peak market cap of £179m just a few years ago but is currently valued by the market at just £19.7m after accounting shenanigans, difficult trading conditions, debt problems and an emergency fundraising. On the face of it, there could be value here, because the shares are trading at a discount of 56% to net asset value at the last balance sheet date (30 September) and at just 0.39 times trailing 12-month sales.

However, 30 September is a long time ago and sales were in decline at that time. More recently, the company reported little headroom on its borrowing facilities at 31 March, saying it was “utilising £17.2m out of its total facilities of £18.3m”.

In today’s announcement, Stanley Gibbons formally put itself up for sale, saying further investment is required. At the same time, Disruptive Capital announced it didn’t have key information “to evaluate whether or not to make an offer” and is not making one. Similarly, I think there’s currently insufficient information to evaluate whether the shares are good or poor value at their current level.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »